Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine

Journal of Neurochemistry

Volumn 123, Issue 5, 2012, Pages 845-855

  Barker Haliski, Melissa L ^a   Oldenburger, Katharina ^a   Keefe, Kristen A ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arc Arg 3.1; dopamine; immediate early gene; methamphetamine; striatum

Indexed keywords

MESSENGER RNA; METHAMPHETAMINE;

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL LOSS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; EFFERENT NERVE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE TRANSFER; GENETIC REGULATION; IMMEDIATE EARLY GENE; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MONOAMINE NERVE CELL; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; TRANSCRIPTION INITIATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; CYTOSKELETAL PROTEINS; DOPAMINE; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NEURONS, EFFERENT; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

ANIMALIA; RATTUS;

EID: 84868660962     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12017     Document Type: Article

References (65)

1. Ali S. F., Newport G. D., Holson R. R., Slikker Jr W., and, Bowyer J. F., (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658, 33-38.
2. Andre V. M., Cepeda C., Cummings D. M., Jocoy E. L., Fisher Y. E., William Yang X., and, Levine M. S., (2010) Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. Eur. J. Neurosci. 31, 14-28.
3. Baez M. V., Luchelli L., Maschi D., Habif M., Pascual M., Thomas M. G., and, Boccaccio G. L., (2011) Smaug1 mRNA-silencing foci respond to NMDA and modulate synapse formation. J. Cell Biol. 195, 1141-1157.
4. Belcher A. M., O'Dell S. J., and, Marshall J. F., (2009) Long-term changes in dopamine-stimulated gene expression after single-day methamphetamine exposure. Synapse 63, 403-412.
5. Bergstrom B. P., and, Garris P. A., (2003) "Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J. Neurochem. 87, 1224-1236.
6. Bloomer W. A., VanDongen H. M., and, VanDongen A. M., (2008) Arc/Arg3.1 translation is controlled by convergent N-methyl-D-aspartate and Gs-coupled receptor signaling pathways. J. Biol. Chem. 283, 582-592.
7. Boja J. W., Mitchell W. M., Patel A., Kopajtic T. A., Carroll F. I., Lewin A. H., Abraham P., and, Kuhar M. J., (1992) High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12, 27-36.
8. Bramham C. R., Worley P. F., Moore M. J., and, Guzowski J. F., (2008) The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J. Neurosci. 28, 11760-11767.
9. Brennan K. A., Colussi-Mas J., Carati C., Lea R. A., Fitzmaurice P. S., and, Schenk S., (2010) Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat. Brain Res. 1317, 137-146.
10. Callaghan R. C., Cunningham J. K., Sykes J., and, Kish S. J., (2012) Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend. 120, 35-40.
11. Cepeda C., Buchwald N. A., and, Levine M. S., (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl Acad. Sci. USA 90, 9576-9580.
12. Chapman D. E., Hanson G. R., Kesner R. P., and, Keefe K. A., (2001) Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J. Pharmacol. Exp. Ther. 296, 520-527.
13. Chawla M. K., Guzowski J. F., Ramirez-Amaya V., Lipa P., Hoffman K. L., Marriott L. K., Worley P. F., McNaughton B. L., and, Barnes C. A., (2005) Sparse, environmentally selective expression of Arc RNA in the upper blade of the rodent fascia dentata by brief spatial experience. Hippocampus 15, 579-586.
14. Chergui K., Svenningsson P., Nomikos G. G., Gonon F., Fredholm B. B., and, Svennson T. H., (1997) Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur. J. Neurosci. 9, 2370-2382.
15. Chowdhury S., Shepherd J. D., Okuno H., Lyford G., Petralia R. S., Plath N., Kuhl D., Huganir R. L., and, Worley P. F., (2006) Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52, 445-459.
16. Daberkow D. P., Riedy M. D., Kesner R. P., and, Keefe K. A., (2007) Arc mRNA induction in striatal efferent neurons associated with response learning. Eur. J. Neurosci. 26, 228-241.
17. Daberkow D. P., Riedy M. D., Kesner R. P., and, Keefe K. A., (2008) Effect of methamphetamine neurotoxicity on learning-induced Arc mRNA expression in identified striatal efferent neurons. Neurotox. Res. 14, 307-315.
18. Dreyer J. K., Herrik K. F., Berg R. W., and, Hounsgaard J. D., (2010) Influence of phasic and tonic dopamine release on receptor activation. J. Neurosci. 30, 14273-14283.
19. Ferguson S. M., and, Robinson T. E., (2004) Amphetamine-evoked gene expression in striatopallidal neurons: regulation by corticostriatal afferents and the ERK/MAPK signaling cascade. J. Neurochem. 91, 337-348.
20. Ferguson S. A., Gough B. J., and, Cada A. M., (2003) In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male rats. Physiol. Behav. 80, 109-114.
21. Floresco S. B., West A. R., Ash B., Moore H., and, Grace A. A., (2003) Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat. Neurosci. 6, 968-973.
22. Ganguly A., and, Keefe K. A., (2001) Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons. Neuroscience 103, 405-412.
23. Gerfen C. R., and, Young III W. S., (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161-167.
24. Giorgi C., Yeo G. W., Stone M. E., Katz D. B., Burge C., Turrigiano G., and, Moore M. J., (2007) The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression. Cell 130, 179-191.
25. Gonon F., (1997) Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J. Neurosci. 17, 5972-5978.
26. Grillner S., Hellgren J., Menard A., Saitoh K., and, Wikstrom M. A., (2005) Mechanisms for selection of basic motor programs-roles for the striatum and pallidum. Trends Neurosci. 28, 364-370.
27. Gross N. B., and, Marshall J. F., (2009) Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression. Neuroscience 161, 1114-1125.
28. Guzowski J. F., McNaughton B. L., Barnes C. A., and, Worley P. F., (1999) Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles. Nat. Neurosci. 2, 1120-1124.
29. Guzowski J. F., Lyford G. L., Stevenson G. D., Houston F. P., McGaugh J. L., Worley P. F., and, Barnes C. A., (2000) Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. 20, 3993-4001.
30. Guzowski J. F., Miyashita T., Chawla M. K., Sanderson J., Maes L. I., Houston F. P., Lipa P., McNaughton B. L., Worley P. F., and, Barnes C. A., (2006) Recent behavioral history modifies coupling between cell activity and Arc gene transcription in hippocampal CA1 neurons. Proc. Natl Acad. Sci. USA 103, 1077-1082.
31. Hearing M. C., Schwendt M., and, McGinty J. F., (2011) Suppression of activity-regulated cytoskeleton-associated gene expression in the dorsal striatum attenuates extinction of cocaine-seeking. Int. J. Neuropsychopharmacol. 14, 784-795.
32. Howard C. D., Keefe K. A., Garris P. A., and, Daberkow D. P., (2011) Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. J. Neurochem. 118, 668-676.
33. Jocoy E. L., Andre V. M., Cummings D. M., Rao S. P., Wu N., Ramsey A. J., Caron M. G., Cepeda C., and, Levine M. S., (2011) Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum. Front. Syst. Neurosci. 5, 28.
34. Johanson C. E., Frey K. A., Lundahl L. H., et al,. (2006) Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology 185, 327-338.
35. Johnson-Davis K. L., Hanson G. R., and, Keefe K. A., (2002) Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression. J. Neurochem. 82, 1472-1479.
36. Kalechstein A. D., Newton T. F., and, Green M., (2003) Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J. Neuropsychiatry Clin. Neurosci. 15, 215-220.
37. Kilkenny C., Browne W. J., Cuthill I. C., Emerson M., and, Altman D. G., (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412.
38. Korb E., and, Finkbeiner S., (2011) Arc in synaptic plasticity: from gene to behavior. Trends Neurosci. 34, 591-598.
39. Krasnova I. N., Justinova Z., Ladenheim B., Jayanthi S., McCoy M. T., Barnes C., Warner J. E., Goldberg S. R., and, Cadet J. L., (2010) Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS ONE 5, e8790.
40. Lyford G. L., Yamagata K., Kaufmann W. E., Barnes C. A., Sanders L. K., Copeland N. G., Gilbert D. J., Jenkins N. A., Lanahan A. A., and, Worley P. F., (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433-445.
41. Mark K. A., Quinton M. S., Russek S. J., and, Yamamoto B. K., (2007) Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. J. Neurosci. 27, 6823-6831.
42. McFadden L. M., Hadlock G. C., Allen S. C., et al,. (2012) Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. J. Pharmacol. Exp. Ther. 340, 295-303.
43. Nisenbaum L. K., Crowley W. R., and, Kitai S. T., (1996) Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Brain Res. Mol. Brain Res. 37, 209-216.
44. Obeso J. A., Rodriguez M. C., and, DeLong M. R., (1997) Basal ganglia pathophysiology. A critical review. Adv. Neurol. 74, 3-18.
45. Onn S. P., West A. R., and, Grace A. A., (2000) Dopamine-mediated regulation of striatal neuronal and network interactions. Trends Neurosci. 23, S48-S56.
46. Pascoli V., Besnard A., Herve D., Pages C., Heck N., Girault J. A., Caboche J., and, Vanhoutte P., (2011) Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation. Biol. Psychiatry 69, 218-227.
47. Pastuzyn E. D., Chapman D. E., Wilcox K. S., and, Keefe K. A., (2012) Altered learning and arc-regulated consolidation of learning in striatum by methamphetamine-induced neurotoxicity. Neuropsychopharmacology 37, 885-895.
48. Paxinos G., and, Watson C,. (1998) The rat brain in stereotaxic coordinates. Academic Press, San Diego.
49. Pintchovski S. A., Peebles C. L., Kim H. J., Verdin E., and, Finkbeiner S., (2009) The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons. J. Neurosci. 29, 1525-1537.
50. Rao V. R., Pintchovski S. A., Chin J., Peebles C. L., Mitra S., and, Finkbeiner S., (2006) AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc. Nat. Neurosci. 9, 887-895.
51. Reichel C. M., Chan C. H., Ghee S. M., and, See R. E., (2012) Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats. Psychopharmacology 223, 371-380.
52. Rial Verde E. M., Lee-Osbourne J., Worley P. F., Malinow R., and, Cline H. T., (2006) Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron 52, 461-474.
53. Schwendt M., Rocha A., See R. E., Pacchioni A. M., McGinty J. F., and, Kalivas P. W., (2009) Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J. Pharmacol. Exp. Ther. 331, 555-562.
54. Son J. H., Latimer C., and, Keefe K. A., (2011) Impaired formation of stimulus-response, but not action-outcome, associations in rats with methamphetamine-induced neurotoxicity. Neuropsychopharmacology 36, 2441-2451.
55. Steiner H., and, Kitai S. T., (2000) Regulation of rat cortex function by D1 dopamine receptors in the striatum. J. Neurosci. 20, 5449-5460.
56. Thomas D. M., Francescutti-Verbeem D. M., Liu X., and, Kuhn D. M., (2004) Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment-an oligonucleotide microarray approach. J. Neurochem. 88, 380-393.
57. Unal C. T., Beverley J. A., Willuhn I., and, Steiner H., (2009) Long-lasting dysregulation of gene expression in corticostriatal circuits after repeated cocaine treatment in adult rats: effects on zif 268 and homer 1a. Eur. J. Neurosci. 29, 1615-1626.
58. Valjent E., Pascoli V., Svenningsson P., et al,. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl Acad. Sci. USA 102, 491-496.
59. Vazdarjanova A., Ramirez-Amaya V., Insel N., et al,. (2006) Spatial exploration induces ARC, a plasticity-related immediate-early gene, only in calcium/calmodulin-dependent protein kinase II-positive principal excitatory and inhibitory neurons of the rat forebrain. J. Comp. Neurol. 498, 317-329.
60. Volkow N. D., Chang L., Wang G. J., et al,. (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158, 377-382.
61. Wagner G. C., Ricaurte G. A., Seiden L. S., Schuster C. R., Miller R. J., and, Westley J., (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181, 151-160.
62. Wichmann T., and, DeLong M. R., (1996) Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6, 751-758.
63. Woolverton W. L., Ricaurte G. A., Forno L. S., and, Seiden L. S., (1989) Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486, 73-78.
64. Yano M., Beverley J. A., and, Steiner H., (2006) Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects. Neuroscience 140, 699-709.
65. Yoshikawa K., Williams C., and, Sabol S. L., (1984) Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem. 259, 14301-14308.